Search

Search Results
Results 4471 - 4480 of 4839 for multiple sclerosis
  • News - 15 Jun 2004
    Scientists at the University of Nebraska Medical Center in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain...
  • Drug - 20 Jul 2026
    Consumer Medicine Information (CMI) about Trazent intended for persons living in Australia.
  • Drug - 18 May 2026
    Consumer Medicine Information (CMI) about Terimide intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Mavenclad intended for persons living in Australia.
  • Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Cladritab intended for persons living in Australia.
  • News - 2 Dec 2025
    On vacation in Mexico last year, Michael DiPlacido passed out twice while scuba diving and again in his hotel. Back in St. Louis, doctors diagnosed him with amyotrophic lateral sclerosis, or ALS, an...
  • News - 12 Nov 2025
    One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic lupus erythematosus or, colloquially, lupus, Stanford Medicine investigators...
  • News - 28 Oct 2025
    Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), represent a growing global health...
  • White Paper - 26 Aug 2025
    Discover how transcription factors are revolutionizing drug discovery.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.